Legal Representation
Attorney
Eric Lamb
USPTO Deadlines
Next Deadline
1745 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241001)
Due Date
October 01, 2030
Grace Period Ends
April 01, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 1, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 1, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 28, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Aug 28, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jul 7, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 29, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jul 6, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 29, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 6, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 12, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 12, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 22, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 3, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 3, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 3, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 3, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 3, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 31, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 4, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Aug 3, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 6, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 040
Custom assembling of materials for others; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of antibody-drug conjugates; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates; processing of pharmaceutical preparations; processing or treating of chemical reagents; processing of antibody drugs; custom manufacturing of antibody drugs; processing of biomedical preparations; processing of biotechnology drug
First Use Anywhere:
Oct 20, 2023
First Use in Commerce:
Oct 20, 2023
Class 042
Development of products for others in the field of pharmaceuticals; pharmaceutical drug development services; research and development of new products in the field of pharmaceuticals; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of conjugated antibodies; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates; preclinical research and evaluation of new drugs; consulting services in the field of technology development; research and development of new products for others; scientific research and development
First Use Anywhere:
Oct 20, 2023
First Use in Commerce:
Oct 20, 2023
Additional Information
Design Mark
The mark consists of the stylized wording "XDC" to the right of an incomplete oval outline that intersects with another incomplete oval outline. The stylized wording "The Bioconjugation Leader" appears below "XDC".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOCONJUGATION"